Interleukin-6 (IL-6)

Introduction

Interleukin 6 (Il 6) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

flowchart TD
    entities_interleukin_6["Interleukin-6 IL-6"]
    entities_interleukin_6_1["Introduction"]
    entities_interleukin_6 -->|"related to"| entities_interleukin_6_1
    style entities_interleukin_6_1 fill:#81c784,stroke:#333,color:#000
    entities_interleukin_6_2["important"]
    entities_interleukin_6 -->|"related to"| entities_interleukin_6_2
    style entities_interleukin_6_2 fill:#81c784,stroke:#333,color:#000
    entities_interleukin_6_3["component"]
    entities_interleukin_6 -->|"related to"| entities_interleukin_6_3
    style entities_interleukin_6_3 fill:#81c784,stroke:#333,color:#000
    entities_interleukin_6_4["neurobiology"]
    entities_interleukin_6 -->|"related to"| entities_interleukin_6_4
    style entities_interleukin_6_4 fill:#81c784,stroke:#333,color:#000
    style entities_interleukin_6 fill:#4fc3f7,stroke:#333,color:#000

Interleukin-6 (IL-6) is a pleiotropic cytokine with critical roles in immune regulation, inflammation, and neuronal survival. IL-6 is implicated in the pathogenesis of multiple neurodegenerative diseases and is a target for therapeutic intervention

Biology of IL-6

Structure and Receptors

IL-6 is a 21-28 kDa glycoprotein cytokine that signals through two distinct mechanisms: ^{2A meta-analysis of cytokines in Alzheimer's disease2010 · Biol Psychiatry · DOI 10.1016/j.biopsych.2010.06.012Open reference}

• Classical signaling: IL-6 binds to membrane-bound IL-6Rα, then recruits gp130

• Trans-signaling: IL-6 binds to soluble IL-6R (sIL-6R), enabling cells that only express gp130 to respond

IL-6 Signaling Pathways

Upon binding to IL-6R/gp130 complexes: ^{3Aberrations in peripheral inflammatory cytokine levels in Parkinson's disease: a systematic review and meta-analysis2016 · Front Immunol · DOI 10.3389/fimmu.2016.00274Open reference}

• JAK/STAT pathway: STAT3 activation and nuclear translocation

• MAPK pathway: Ras-Raf-MEK-ERK cascade

• PI3K/Akt pathway: Cell survival signaling

The balance between classical and trans-signaling determines the biological outcome, with trans-signaling often pro-inflammatory. ^{4IL-6 in CNS autoimmunity2010 · Adv Exp Med Biol · DOI 10.1007/978-1-4419-5912-3_4Open reference}

Production in the CNS

In the central nervous system, IL-6 is produced by various cell types: ^{5IL-6 and disease progression in amyotrophic lateral sclerosis2019 · Neurology · DOI 10.1212/WNL.0000000000007939Open reference}

• Astrocytes: Major producers under resting and activated conditions

• Microglia: Rapid responders to injury and infection

• Neurons: Produce IL-6 in response to excitotoxicity

• Oligodendrocytes: Contribute to demyelinating conditions

Role in Neurodegeneration

Alzheimer’s Disease

IL-6 is elevated in the brains, CSF, and blood of Alzheimer’s disease patients^{2A meta-analysis of cytokines in Alzheimer's disease2010 · Biol Psychiatry · DOI 10.1016/j.biopsych.2010.06.012Open reference}: ^{6IL-6 and its receptor in autoimmunity2017 · Nat Rev Immunol · DOI 10.1038/nri.2017.22Open reference}

• Promotes amyloid-beta production and aggregation

• Contributes to tau pathology through kinase activation

• Drives chronic neuroinflammation

• Associated with disease severity and progression

The amyloid-beta-IL-6 axis represents a key pathway in AD pathogenesis, where amyloid plaques stimulate IL-6 production, which in turn enhances amyloid processing.

Parkinson’s Disease

Elevated IL-6 is found in the substantia nigra, striatum, and CSF of PD patients^{3Aberrations in peripheral inflammatory cytokine levels in Parkinson's disease: a systematic review and meta-analysis2016 · Front Immunol · DOI 10.3389/fimmu.2016.00274Open reference}:

• Contributes to dopaminergic neuron vulnerability

• Activates microglia and astrocytes

• Linked to disease duration and severity

IL-6 polymorphisms have been associated with increased PD risk, suggesting a genetic component to IL-6-mediated neurodegeneration.

Stroke and Ischemia

IL-6 has both detrimental and protective roles in cerebral ischemia^{4IL-6 in CNS autoimmunity2010 · Adv Exp Med Biol · DOI 10.1007/978-1-4419-5912-3_4Open reference}:

• Acute elevation contributes to excitotoxic damage

• IL-6 has neuroprotective properties through STAT3 activation

• Post-stroke IL-6 levels predict outcomes

The timing of IL-6 modulation may determine whether its effects are beneficial or harmful.

Amyotrophic Lateral Sclerosis (ALS)

Elevated IL-6 in CSF and serum correlates with progression in ALS patients^{5IL-6 and disease progression in amyotrophic lateral sclerosis2019 · Neurology · DOI 10.1212/WNL.0000000000007939Open reference}:

• Contributes to motor neuron injury

• Activates glial cells

• Associated with faster disease progression

Multiple Sclerosis (MS)

IL-6 promotes Th17 differentiation and demyelination in MS^{2A meta-analysis of cytokines in Alzheimer's disease2010 · Biol Psychiatry · DOI 10.1016/j.biopsych.2010.06.012Open reference}0:

• Drives autoimmune responses

• Impairs blood-brain barrier integrity

• Therapeutic targeting shows promise

Huntington’s Disease

Increased IL-6 is found in the striatum and cortex of HD patients:

• Contributes to medium spiny neuron dysfunction

• Associated with CAG repeat length

• Potential biomarker for disease progression

Therapeutic Targeting

IL-6 Receptor Antibodies

Therapeutic strategies targeting IL-6 include:

1. Tocilizumab: Humanized anti-IL-6R antibody, FDA-approved for rheumatoid arthritis

2. Sarilumab: Fully human anti-IL-6R antibody

3. Siltuximab: Chimeric anti-IL-6 antibody

4. Satralizumab: Aquaporin-4 antibody for NMOSD

Clinical Considerations

• CNS penetration: Limited, but peripheral effects may modulate neuroinflammation

• Clinical trials: Ongoing for Alzheimer’s, Parkinson’s, and ALS

• Biomarker potential: IL-6 as a biomarker for disease progression

• Genetic studies: IL-6 polymorphisms linked to neurodegeneration risk

Alternative Approaches

• JAK inhibitors: Block downstream signaling

• STAT3 inhibitors: Target nuclear translocation

• Soluble gp130: Neutralize trans-signaling

Research Methods

Detection Techniques

• ELISA: Quantify IL-6 in CSF and serum

• Immunohistochemistry: Localize IL-6 in brain tissue

• qPCR: Measure IL-6 mRNA expression

• Multiplex assays: Profile multiple cytokines simultaneously

Animal Models

• IL-6 transgenic mice: Overexpress IL-6 in CNS

• IL-6 knockout mice: Study loss-of-function

• AAV-mediated delivery: Targeted CNS expression

Future Research Directions

Current research focuses on understanding the dual nature of IL-6 signaling in the CNS. Selective targeting of trans-signaling while preserving classical signaling represents a promising therapeutic approach. Biomarker studies are evaluating IL-6 levels for disease diagnosis and treatment response prediction.

Key research priorities include:

• Developing CNS-penetrant IL-6 inhibitors

• Identifying patient subgroups who may benefit most from treatment

• Understanding IL-6 interactions with other cytokines

• Exploring IL-6 as a biomarker for clinical trials

See Also

• Microglia

• Neuroinflammation

• JAK/STAT Signaling

• Alzheimer’s Disease

• Parkinson’s Disease

• Cytokines

External Links

• IL-6 Wikipedia

• Cytokines and Inflammation (NIAID)

• Neuroinflammation Research (Nature)

Background

The study of Interleukin 6 (Il 6) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

• Allen Human Brain Atlas - IL6 Expression: Gene expression data in human brain

• Allen Mouse Brain Atlas - IL6: Mouse brain expression patterns

• BrainSpan - Developmental Transcriptome: Developmental expression data